Alexander Kotsinas

CFO, Finance and Executive Vice President

Ulrika Köhler

Executive Vice President, Biomedical Development

2 past transactions

Metabogen

Acquisition in 2018
Metabogen is an operator of a research and development company intended to offer biomarker and personalized treatment services. The company's services include integrating metagenomic data analysis with subsequent development and clinical programs as well as specializes in the identification and improvisation of indication-related bacterial strains, enabling probiotic industry to develop novel diagnostic tests and treatments.

Metabogen

Corporate Round in 2018
Metabogen is an operator of a research and development company intended to offer biomarker and personalized treatment services. The company's services include integrating metagenomic data analysis with subsequent development and clinical programs as well as specializes in the identification and improvisation of indication-related bacterial strains, enabling probiotic industry to develop novel diagnostic tests and treatments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.